Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2002-08-30 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: EPOUVILLE (76133), Seine-Maritime
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE D'EPOUVILLE : revenue, balance sheet and financial ratios
SELAS PHARMACIE D'EPOUVILLE is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in EPOUVILLE (76133),
this company of category PME
shows in 2020 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE D'EPOUVILLE (SIREN 443445069)
Indicator
2025
2024
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
2 925 918 €
N/C
N/C
N/C
N/C
Net income
282 550 €
222 721 €
372 297 €
379 698 €
251 335 €
207 370 €
214 313 €
136 979 €
119 046 €
EBITDA
N/C
N/C
N/C
N/C
334 427 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
8.6%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELAS PHARMACIE D'EPOUVILLE generates positive net income of 283 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 119 k€ -> 283 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
282 550 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 28%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
27.768%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.117%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Debt ratio
23.472
32.381
32.19
20.113
38.913
44.362
66.247
36.986
27.768
Financial autonomy
63.058
61.121
63.485
68.6
58.959
56.562
49.521
59.317
63.117
Repayment capacity
None
None
None
None
1.541
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
8.528%
None%
None%
None%
None%
Sector positioning
Debt ratio
27.772025
2022
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-11 pts over 3 years
In 2025, the debt ratio of SELAS PHARMACIE D'EPOUVILLE (27.77) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
63.12%2025
2022
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+10 pts over 3 years
In 2025, the financial autonomy of SELAS PHARMACIE D'EPOUVILLE (63.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 274.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Liquidity ratio
110.87
158.257
221.784
209.907
224.446
265.803
281.58
267.92
274.17
Interest coverage
None
None
None
None
1.497
None
None
None
None
Sector positioning
Liquidity ratio
274.172025
2022
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of SELAS PHARMACIE D'EPOUVILLE (274.17) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELAS PHARMACIE D'EPOUVILLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
293 791 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
35
0
0
0
0
Customer payment term (days)
125
75
0
0
6
0
0
0
0
Supplier payment term (days)
1162
542
0
0
37
0
0
0
0
Positioning of SELAS PHARMACIE D'EPOUVILLE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELAS PHARMACIE D'EPOUVILLE is estimated at
4 488 340 €
(range 3 045 808€ - 7 042 824€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3045k€4488k€7042k€
4 488 340 €Range: 3 045 808€ - 7 042 824€
NAF 5 année 2025
Valuation method used
Net Income Multiple
282 550 €
×
15.9x
=4 488 340 €
Range: 3 045 809€ - 7 042 824€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE D'EPOUVILLE with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE D'EPOUVILLE
What is the revenue of SELAS PHARMACIE D'EPOUVILLE ?
The revenue of SELAS PHARMACIE D'EPOUVILLE in 2020 is 2.9 M€.
Is SELAS PHARMACIE D'EPOUVILLE profitable?
Yes, SELAS PHARMACIE D'EPOUVILLE generated a net profit of 283 k€ in 2025.
Where is the headquarters of SELAS PHARMACIE D'EPOUVILLE ?
The headquarters of SELAS PHARMACIE D'EPOUVILLE is located in EPOUVILLE (76133), in the department Seine-Maritime.
Where to find the tax return of SELAS PHARMACIE D'EPOUVILLE ?
The tax return of SELAS PHARMACIE D'EPOUVILLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE D'EPOUVILLE operate?
SELAS PHARMACIE D'EPOUVILLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart